Embecta Corp. (EMBC)
6.45
+0.27
(+4.37%)
USD |
NASDAQ |
Oct 15, 16:00
6.435
-0.02
(-0.23%)
After-Hours: 20:00
Embecta Cash from Operations (TTM) : 174.10M for June 30, 2026
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 174.10M |
| March 31, 2026 | 213.50M |
| December 31, 2025 | 214.20M |
| September 30, 2025 | 191.70M |
| June 30, 2025 | 134.30M |
| March 31, 2025 | 51.00M |
| December 31, 2024 | 43.50M |
| September 30, 2024 | 35.70M |
| June 30, 2024 | 38.70M |
| Date | Value |
|---|---|
| March 31, 2024 | 31.50M |
| December 31, 2023 | -5.80M |
| September 30, 2023 | 67.70M |
| June 30, 2023 | 96.10M |
| March 31, 2023 | 138.20M |
| December 31, 2022 | 333.80M |
| September 30, 2022 | 412.20M |
| June 30, 2022 | 439.40M |
| March 31, 2022 | 536.30M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Artivion, Inc. | 41.71M |
| Abbott Laboratories | 9.905B |
| AngioDynamics, Inc. | 3.673M |
| Alphatec Holdings, Inc. | 56.52M |
| AtriCure, Inc. | 64.94M |